CARGO Therapeutics, Inc.
CRGX
$4.12
$0.071.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.92% | -5.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.41% | -4.47% | |||
| Operating Income | -6.41% | 4.47% | |||
| Income Before Tax | -8.42% | 5.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.42% | 5.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.42% | 5.50% | |||
| EBIT | -6.41% | 4.47% | |||
| EBITDA | -6.36% | 4.73% | |||
| EPS Basic | -8.03% | 14.07% | |||
| Normalized Basic EPS | -8.04% | 14.07% | |||
| EPS Diluted | -8.03% | 14.07% | |||
| Normalized Diluted EPS | -8.04% | 14.07% | |||
| Average Basic Shares Outstanding | 0.36% | 9.97% | |||
| Average Diluted Shares Outstanding | 0.36% | 9.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||